Review Papers | Medicine | India | Volume 9 Issue 9, September 2020
Interleukin 6: The Best Marker for COVID-19 Disease Severity
Abstract: SARS CoV-2 has killed more than 60000 people in India alone till September 2020 and caused severe burden on health infrastructure of the country. There is a need for early and accurate predictors of severe infection at the early stage so that people can be triaged. Covid-19 presents with an array of symptoms ranging from asymptomatic to mild cough and cold to high grade fever and difficulty in breathing. There are many cases in which mild cases progressed to life threatening condition in a matter of a couple of hours. So, there is a need for a marker that can predict severity of the disease. Cytokines are synthesised in the body during infection and they can be used to predict severity of Covid-19 infection. In our study we are trying to prove IL-6 and IL-10 to be ideal candidates for prediction of Covid-19 disease severity.
Keywords: COVID-19, SARS CoV-2, Cytokines, IL-6, IL-10
Edition: Volume 9 Issue 9, September 2020,
Pages: 1132 - 1135
How to Cite this Article?
Gagandeep Malik, "Interleukin 6: The Best Marker for COVID-19 Disease Severity", International Journal of Science and Research (IJSR), https://www.ijsr.net/get_abstract.php?paper_id=SR20921102501, Volume 9 Issue 9, September 2020, 1132 - 1135, #ijsrnet
How to Share this Article?
Similar Articles with Keyword 'SARS CoV2'
Pulmonary Thromboembolism - As a Post Covid Sequele in a Mild Category Case (Case Report)
Dr Pasumarthi Chinmai Sai Aparna | Dr Frank Pitchaimuthu | Dr Sonali Trivedi
CT Chest Severity Index in SARS CoV2 - A Tool to Predict Clinical Outcome
Dr. Brunda M S | Dr. Arushi Mohan | Dr. Abhinaya Shekhar  | Dr. Samriddha Thapa | Dr. Harshadayani Jagdish Kumar | Dr. Shabreen Khanum C R | Dr. Padma L